{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:31:13Z","timestamp":1759969873127,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.maturitas.2004.12.006","type":"journal-article","created":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T07:19:03Z","timestamp":1108970343000},"page":"70-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A comparison of raloxifene and calcium plus Vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women"],"prefix":"10.1016","volume":"52","author":[{"given":"M.A.","family":"Checa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Prat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Conangla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Carreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2004.12.006_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2004.12.006_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"HERS research group. Cardiovascular disease outcomes during 6. 8 years of hormone therapy: Heart and Estrogen\/Progestin Replacement Study Follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2004.12.006_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2004.12.006_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-5122(02)00214-1","article-title":"European menopause & andropause society. Results from WHI and HERS II\u2013implications for women and the prescriber of HRT","volume":"42","author":"Neves-e-Castro","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2004.12.006_bib5","first-page":"1225","article-title":"Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy","volume":"102","author":"Ettinger","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.maturitas.2004.12.006_bib7","first-page":"722","article-title":"Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee","volume":"92","author":"Cardozo","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0028-2243(93)90187-H","article-title":"The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms","volume":"51","author":"van der Linden","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5122(02)00336-5","article-title":"Relevant results of the WHI study for the management of the menopause in Spain","volume":"44","author":"Palacios","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2004.12.006_bib10","series-title":"The manual of cytotechnology","first-page":"62","article-title":"Hormonal cytology","author":"Wied","year":"1993"},{"key":"10.1016\/j.maturitas.2004.12.006_bib11","first-page":"249","article-title":"The maturation value","volume":"11","author":"Meisels","year":"1967","journal-title":"Acta Cytol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual frame work and itemselection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.maturitas.2004.12.006_bib13","first-page":"771","article-title":"The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results","volume":"104","author":"Alonso","year":"1995","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.maturitas.2004.12.006_bib14","first-page":"410","article-title":"Population referente values of the Spanish version of the health questionnaire SF-36","volume":"111","author":"Alonso","year":"1998","journal-title":"Med Clin (Barc)"},{"issue":"Suppl. 16","key":"10.1016\/j.maturitas.2004.12.006_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-0528.1997.tb11560.x","article-title":"The need to improve compliance to HRT","volume":"104","author":"Rees","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0378-5122(03)00155-5","article-title":"Compliance with oral HRT in postmenopausal women in clinical trials\u2013meta analysis","volume":"41","author":"Shmuely","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2004.12.006_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0015-0282(02)03108-4","article-title":"Raloxifene treatment increases plasma levels of beta-endorphin in postmenopausal women: a randomized, placebo-controlled study","volume":"77","author":"Neele","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.maturitas.2004.12.006_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1067\/mob.2003.374","article-title":"Short-term urogenital effects of raloxifene, tamoxifen, and estrogen","volume":"189","author":"Vardy","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib19","first-page":"91","article-title":"Raloxifene effect on frequency of surgery for pelvic floor relaxation","volume":"98","author":"Goldstein","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0306-3356(21)00374-5","article-title":"Oestrogen therapy and the menopausal syndrome","volume":"4","author":"Campbell","year":"1977","journal-title":"Clin Obstet Gynaecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib21","first-page":"558","article-title":"Adverse events reported by postmenopausal women in controlled trials with raloxifene","volume":"93","author":"Davies","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000110247.98588.ff","article-title":"Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms","volume":"103","author":"Gordon","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2004.12.006_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000109429.67671.d1","article-title":"Effect of raloxifene on urinary incontinence: a randomised controlled trial","volume":"103","author":"Waetjen","year":"2004","journal-title":"Obstet Gynecol"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512205000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:40:10Z","timestamp":1759912810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512205000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0378512205000034"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2004.12.006","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of raloxifene and calcium plus Vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2004.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}